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Background/purpose
Rheumatoid arthritis (RA) is a prototypic autoimmune dis-
ease characterized by a prominent humoral autoimmunity.
Of particular relevance is the local production of autoanti-
bodies such as rheumatoid factor and anti-citrullinated
protein antibodies in the inflamed synovial tissue. The
mechanisms underlying break of B cell tolerance and local
autoantibody production remains poorly understood. This
study was conducted in order to identify cellular and
molecular pathways implicated in RA-specific humoral
autoimmunity.
Methods
Synovial tissue samples were obtained by arthroscopy
from untreated individuals with RA (n=33) and inflamma-
tion matched SpA controls (n=58). Gene expression profil-
ing was performed on tissue samples of patients with
established arthritis using 44K Whole Genome Human
microarrays (Agilent). Top differentially expressed genes
were validated on three independent cohorts by Taqman
based RT-qPCR and immunohistochemistry. Collagen-
induced arthritis (CIA) and Experimental autoimmune
encephalomyelitis (EAE) experiments were conducted
using Bob1 knockout mice and their littermate controls.
Results
Microarray screening for genes differentially expressed in
the inflamed synovium, the key target of the disease pro-
cess in RA, revealed a prominent and disease-specific B
cell/plasma cell signature with the B cell-specific transcrip-
tional co-activator Bob1 and its transcriptional target
BCMA among the most upregulated genes. Validation by
RT-qPCR on two independent cohorts representing early
and established arthritis confirmed microarray data and
demonstrated elevated expression of Bob1 and BCMA not
only in established RA, but also at the early phase of the
disease. Quantitative evaluation of immunohistochemical
stainings of synovial tissue with monoclonal antibody for
Bob1 revealed significant increase in Bob1 positive cells in
RA synovium (p<0.01). Next we determined whether lack
of functional Bob1 modifies disease onset or severity in
CIA. Interestingly, the results showed that Bob1−/− mice
were fully resistant to CIA induction compared to their
wild-type littermates. This remarkable protection from
CIA is explained by failure to produce pathogenic anti-
collagen autoantibodies in the absence of Bob1. In con-
trast, Bob1−/−mice were susceptible to MOG protein
induced EAE and incidence and severity of clinical disease
were not altered in these mice comparing to wild-type lit-
termates, suggesting that absence of Bob1 does not impact
on antigen-presentation/costimulatory capacity of B cells.
Conclusion
The specific increase in Bob1 expressing cells in RA
synovitis and the resistance of Bob1-defecient mice to
development of CIA indicate that Bob1/BCMA axis may
contribute to humoral autoimmunity in RA. The rela-
tionship between an aberrant Bob1 expression and the
break of peripheral tolerance in RA is currently under
investigation.
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